Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Johnson & Johnson COVID-19 Vaccine List of Ingredients

What We Know About PEG, Suspected as the Cause of Reactions to Pfizer’s COVID-19 Vaccine

Moderna COVID-19 Vaccine List of Ingredients

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Food Allergies Reversed in Mice by Targeting the Microbiome

BlueWillow Awarded NIH Contract to Advance Development of its Therapeutic Peanut...

Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine

Food Allergy Prevention QuickFire Challenge: Up to $150,000 in Grant Funding...

Company Developing Novel Food Allergy Treatment Raises $3.5 Million in Seed...

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

DBV Completes Phase III Study of Peanut Patch

Prota Therapeutics’ PRT120 Awarded for Long-Term Peanut Allergy Remission

Fruit Power: How Pectin Prebiotics Could Offer a New Way to...

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Follow Us

Your School On Our Map

Put Your School on the Map